 Bryan Bergman
Concepts (451)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Insulin Resistance | 52 | 2025 | 1208 | 8.680 |
Why?
| | Muscle, Skeletal | 40 | 2025 | 1724 | 5.650 |
Why?
| | Adipose Tissue | 18 | 2025 | 635 | 3.580 |
Why?
| | Triglycerides | 17 | 2024 | 524 | 3.110 |
Why?
| | Sphingolipids | 8 | 2024 | 77 | 2.810 |
Why?
| | Diabetes Mellitus, Type 2 | 23 | 2024 | 2531 | 2.800 |
Why?
| | Obesity | 35 | 2025 | 2992 | 2.560 |
Why?
| | Exercise | 15 | 2025 | 2057 | 2.510 |
Why?
| | Diglycerides | 8 | 2024 | 61 | 2.340 |
Why?
| | Insulin | 27 | 2025 | 2409 | 2.220 |
Why?
| | Blood Glucose | 29 | 2025 | 2186 | 1.680 |
Why?
| | Fasting | 7 | 2025 | 281 | 1.650 |
Why?
| | Lipid Metabolism | 13 | 2025 | 518 | 1.580 |
Why?
| | Weight Loss | 5 | 2025 | 787 | 1.540 |
Why?
| | Lipids | 5 | 2024 | 672 | 1.500 |
Why?
| | Physical Endurance | 12 | 2020 | 275 | 1.460 |
Why?
| | Glucose Clamp Technique | 22 | 2025 | 195 | 1.460 |
Why?
| | Ceramides | 7 | 2024 | 118 | 1.410 |
Why?
| | Phosphatidylcholines | 2 | 2024 | 147 | 1.310 |
Why?
| | Sarcolemma | 3 | 2024 | 43 | 1.210 |
Why?
| | Rest | 6 | 2017 | 121 | 1.180 |
Why?
| | Paracrine Communication | 2 | 2025 | 65 | 1.100 |
Why?
| | Lipogenesis | 4 | 2017 | 61 | 1.080 |
Why?
| | Muscle Fibers, Skeletal | 5 | 2024 | 218 | 1.080 |
Why?
| | Liver | 12 | 2019 | 1943 | 1.080 |
Why?
| | Fatty Acids, Nonesterified | 10 | 2022 | 159 | 1.010 |
Why?
| | Intra-Abdominal Fat | 4 | 2022 | 91 | 0.950 |
Why?
| | Prediabetic State | 5 | 2016 | 253 | 0.930 |
Why?
| | Glucose | 9 | 2023 | 1020 | 0.880 |
Why?
| | Receptors, Gastrointestinal Hormone | 1 | 2023 | 9 | 0.850 |
Why?
| | Glucagon-Like Peptide 1 | 2 | 2023 | 135 | 0.840 |
Why?
| | Glucose Tolerance Test | 11 | 2021 | 366 | 0.840 |
Why?
| | Pancreas | 1 | 2025 | 329 | 0.790 |
Why?
| | Dietary Fats | 6 | 2020 | 304 | 0.780 |
Why?
| | Subcutaneous Fat | 4 | 2025 | 81 | 0.770 |
Why?
| | Tandem Mass Spectrometry | 4 | 2024 | 532 | 0.770 |
Why?
| | Carnitine | 3 | 2024 | 84 | 0.770 |
Why?
| | Adult | 46 | 2025 | 37929 | 0.740 |
Why?
| | Diabetes Mellitus, Type 1 | 18 | 2019 | 3715 | 0.710 |
Why?
| | Humans | 90 | 2025 | 137585 | 0.700 |
Why?
| | Male | 67 | 2025 | 67762 | 0.690 |
Why?
| | Athletes | 7 | 2024 | 423 | 0.670 |
Why?
| | Female | 65 | 2025 | 73304 | 0.650 |
Why?
| | Energy Metabolism | 5 | 2025 | 922 | 0.610 |
Why?
| | Transcription, Genetic | 1 | 2025 | 1457 | 0.600 |
Why?
| | Glucose Intolerance | 4 | 2014 | 146 | 0.550 |
Why?
| | Middle Aged | 31 | 2025 | 33479 | 0.550 |
Why?
| | Lactic Acid | 7 | 2009 | 305 | 0.540 |
Why?
| | Oxidation-Reduction | 8 | 2024 | 1060 | 0.530 |
Why?
| | Adipocytes | 2 | 2023 | 222 | 0.530 |
Why?
| | Hypoglycemic Agents | 2 | 2023 | 1291 | 0.530 |
Why?
| | Phosphatidylethanolamines | 2 | 2017 | 77 | 0.520 |
Why?
| | Chromatography, High Pressure Liquid | 1 | 2019 | 597 | 0.510 |
Why?
| | Choristoma | 1 | 2015 | 21 | 0.490 |
Why?
| | Body Composition | 10 | 2025 | 684 | 0.480 |
Why?
| | Mitochondria, Muscle | 5 | 2021 | 116 | 0.460 |
Why?
| | Myocardium | 2 | 2009 | 1002 | 0.420 |
Why?
| | Hyperglycemia | 3 | 2014 | 347 | 0.420 |
Why?
| | Smoking | 2 | 2012 | 1627 | 0.410 |
Why?
| | Benzhydryl Compounds | 1 | 2013 | 73 | 0.400 |
Why?
| | Fatty Acids, Monounsaturated | 1 | 2012 | 54 | 0.390 |
Why?
| | Atrial Function | 2 | 2009 | 10 | 0.390 |
Why?
| | Phenols | 1 | 2013 | 99 | 0.390 |
Why?
| | Cross-Sectional Studies | 8 | 2024 | 5472 | 0.390 |
Why?
| | Culture Media, Conditioned | 2 | 2022 | 110 | 0.380 |
Why?
| | Body Mass Index | 7 | 2025 | 2389 | 0.380 |
Why?
| | Islets of Langerhans | 6 | 2025 | 803 | 0.380 |
Why?
| | Adiposity | 5 | 2024 | 518 | 0.380 |
Why?
| | Homeostasis | 1 | 2016 | 621 | 0.380 |
Why?
| | Fatty Acids | 5 | 2024 | 443 | 0.380 |
Why?
| | Lipoprotein Lipase | 2 | 2015 | 59 | 0.370 |
Why?
| | Hyperinsulinism | 3 | 2024 | 121 | 0.370 |
Why?
| | Physical Fitness | 4 | 2004 | 209 | 0.360 |
Why?
| | Glycerol | 5 | 2015 | 94 | 0.350 |
Why?
| | Sex Characteristics | 5 | 2024 | 762 | 0.340 |
Why?
| | Animals | 29 | 2024 | 36940 | 0.340 |
Why?
| | Incretins | 1 | 2010 | 22 | 0.340 |
Why?
| | Sleep | 3 | 2021 | 755 | 0.330 |
Why?
| | Sleep Deprivation | 3 | 2021 | 174 | 0.330 |
Why?
| | Dipeptidyl-Peptidase IV Inhibitors | 1 | 2010 | 47 | 0.330 |
Why?
| | Pyrazines | 1 | 2010 | 90 | 0.320 |
Why?
| | Triazoles | 1 | 2010 | 147 | 0.310 |
Why?
| | Physical Education and Training | 2 | 1999 | 76 | 0.300 |
Why?
| | Cytosol | 2 | 2020 | 226 | 0.300 |
Why?
| | Rats | 6 | 2024 | 5647 | 0.300 |
Why?
| | Insulin-Secreting Cells | 2 | 2010 | 377 | 0.290 |
Why?
| | Cardiac Pacing, Artificial | 1 | 2009 | 87 | 0.290 |
Why?
| | Thinness | 2 | 2007 | 91 | 0.280 |
Why?
| | Energy Intake | 4 | 2025 | 485 | 0.270 |
Why?
| | Endoplasmic Reticulum | 2 | 2020 | 265 | 0.260 |
Why?
| | Pulmonary Gas Exchange | 3 | 2007 | 121 | 0.260 |
Why?
| | T-Lymphocytes | 5 | 2000 | 1996 | 0.250 |
Why?
| | Young Adult | 13 | 2024 | 13209 | 0.240 |
Why?
| | Maternal Nutritional Physiological Phenomena | 2 | 2018 | 176 | 0.240 |
Why?
| | Palmitates | 2 | 2018 | 18 | 0.230 |
Why?
| | Polycystic Ovary Syndrome | 2 | 2019 | 177 | 0.230 |
Why?
| | Heart Rate | 1 | 2008 | 822 | 0.230 |
Why?
| | Adipose Tissue, White | 1 | 2024 | 41 | 0.220 |
Why?
| | Body Weight | 2 | 2025 | 985 | 0.220 |
Why?
| | Citric Acid Cycle | 2 | 2021 | 57 | 0.210 |
Why?
| | Prostatic Neoplasms | 3 | 2020 | 1043 | 0.210 |
Why?
| | Caloric Restriction | 1 | 2025 | 124 | 0.210 |
Why?
| | Circadian Clocks | 1 | 2023 | 50 | 0.210 |
Why?
| | Catecholamines | 1 | 2023 | 98 | 0.210 |
Why?
| | Mice, Inbred NOD | 5 | 2015 | 601 | 0.210 |
Why?
| | Mitochondrial Diseases | 1 | 2023 | 91 | 0.200 |
Why?
| | Adiponectin | 3 | 2015 | 244 | 0.200 |
Why?
| | Isophane Insulin, Human | 1 | 2022 | 5 | 0.200 |
Why?
| | Intracellular Signaling Peptides and Proteins | 2 | 2017 | 455 | 0.200 |
Why?
| | Matrix Metalloproteinase 1 | 1 | 2022 | 22 | 0.200 |
Why?
| | Fatty Liver | 2 | 2016 | 243 | 0.200 |
Why?
| | Ribonucleoside Diphosphate Reductase | 1 | 2022 | 6 | 0.200 |
Why?
| | Gluconeogenesis | 2 | 2018 | 79 | 0.200 |
Why?
| | Adipokines | 1 | 2022 | 49 | 0.190 |
Why?
| | Oxygen Consumption | 4 | 2016 | 696 | 0.190 |
Why?
| | Plasminogen Activator Inhibitor 1 | 1 | 2022 | 86 | 0.190 |
Why?
| | Blotting, Western | 3 | 2016 | 1226 | 0.190 |
Why?
| | Biopsy | 3 | 2018 | 1129 | 0.190 |
Why?
| | Dinoprostone | 1 | 2022 | 191 | 0.190 |
Why?
| | Subcellular Fractions | 2 | 2021 | 82 | 0.190 |
Why?
| | Histone Deacetylase Inhibitors | 1 | 2023 | 210 | 0.190 |
Why?
| | Histone Deacetylases | 1 | 2023 | 215 | 0.190 |
Why?
| | Vasodilation | 1 | 2025 | 499 | 0.180 |
Why?
| | Case-Control Studies | 5 | 2019 | 3556 | 0.180 |
Why?
| | Interleukin-13 | 1 | 2022 | 149 | 0.180 |
Why?
| | Bone Marrow | 1 | 2023 | 286 | 0.180 |
Why?
| | Stearoyl-CoA Desaturase | 3 | 2012 | 65 | 0.180 |
Why?
| | Physical Conditioning, Animal | 1 | 2024 | 257 | 0.180 |
Why?
| | Interleukin-8 | 1 | 2022 | 268 | 0.180 |
Why?
| | Exercise Test | 5 | 2015 | 625 | 0.180 |
Why?
| | Resistance Training | 1 | 2024 | 164 | 0.180 |
Why?
| | Lipolysis | 2 | 2018 | 46 | 0.180 |
Why?
| | Bone Remodeling | 1 | 2021 | 75 | 0.170 |
Why?
| | Knee | 1 | 2001 | 68 | 0.170 |
Why?
| | Diabetic Angiopathies | 3 | 2011 | 259 | 0.170 |
Why?
| | Electric Stimulation | 1 | 2001 | 264 | 0.160 |
Why?
| | Antigens, Surface | 1 | 2000 | 154 | 0.160 |
Why?
| | Immunity | 1 | 2020 | 143 | 0.160 |
Why?
| | Diabetic Neuropathies | 1 | 2021 | 94 | 0.160 |
Why?
| | Autophagy-Related Proteins | 2 | 2017 | 46 | 0.160 |
Why?
| | Hematopoietic Stem Cells | 1 | 2023 | 406 | 0.160 |
Why?
| | Palmitic Acid | 2 | 2010 | 41 | 0.160 |
Why?
| | Autoantigens | 2 | 2000 | 430 | 0.150 |
Why?
| | Calorimetry, Indirect | 3 | 2019 | 84 | 0.150 |
Why?
| | Heparin, Low-Molecular-Weight | 1 | 2018 | 34 | 0.150 |
Why?
| | Guanosine Triphosphate | 1 | 2018 | 91 | 0.150 |
Why?
| | rac1 GTP-Binding Protein | 1 | 2018 | 56 | 0.150 |
Why?
| | Obesity, Abdominal | 1 | 2018 | 48 | 0.150 |
Why?
| | Kinetics | 6 | 2006 | 1670 | 0.150 |
Why?
| | Primary Cell Culture | 1 | 2019 | 171 | 0.140 |
Why?
| | Interleukin-6 | 1 | 2022 | 778 | 0.140 |
Why?
| | Absorptiometry, Photon | 4 | 2025 | 259 | 0.140 |
Why?
| | Basal Metabolism | 2 | 2008 | 61 | 0.140 |
Why?
| | Muscle Contraction | 1 | 2001 | 424 | 0.140 |
Why?
| | Non-alcoholic Fatty Liver Disease | 2 | 2018 | 279 | 0.140 |
Why?
| | Metabolic Syndrome | 2 | 2013 | 354 | 0.140 |
Why?
| | Mice | 14 | 2024 | 17787 | 0.140 |
Why?
| | Small Cell Lung Carcinoma | 1 | 2018 | 96 | 0.140 |
Why?
| | Cohort Studies | 5 | 2021 | 5742 | 0.140 |
Why?
| | Tumor Necrosis Factor-alpha | 1 | 2022 | 1242 | 0.140 |
Why?
| | Cell Nucleus | 1 | 2020 | 620 | 0.140 |
Why?
| | Diet | 4 | 2013 | 1278 | 0.140 |
Why?
| | Diet, Western | 3 | 2023 | 81 | 0.130 |
Why?
| | Lung Neoplasms | 2 | 2022 | 2526 | 0.130 |
Why?
| | Autophagy-Related Protein-1 Homolog | 1 | 2017 | 7 | 0.130 |
Why?
| | Extracellular Vesicles | 2 | 2018 | 146 | 0.130 |
Why?
| | Pediatric Obesity | 1 | 2024 | 601 | 0.130 |
Why?
| | Adaptor Proteins, Vesicular Transport | 1 | 2017 | 45 | 0.130 |
Why?
| | Metabolomics | 3 | 2019 | 678 | 0.130 |
Why?
| | Phospholipids | 3 | 2018 | 223 | 0.130 |
Why?
| | Biological Transport | 1 | 2017 | 418 | 0.130 |
Why?
| | Pregnancy | 7 | 2024 | 6763 | 0.120 |
Why?
| | Phosphorylation | 4 | 2015 | 1759 | 0.120 |
Why?
| | Sequence Analysis, RNA | 1 | 2019 | 452 | 0.120 |
Why?
| | Gene Expression Profiling | 2 | 2023 | 1774 | 0.120 |
Why?
| | Phenotype | 1 | 2024 | 3196 | 0.120 |
Why?
| | Fatty Acids, Unsaturated | 1 | 2016 | 99 | 0.120 |
Why?
| | Metformin | 1 | 2019 | 331 | 0.120 |
Why?
| | Microtubule-Associated Proteins | 1 | 2017 | 196 | 0.120 |
Why?
| | Insulin Receptor Substrate Proteins | 2 | 2012 | 59 | 0.120 |
Why?
| | Insulinoma | 2 | 1999 | 26 | 0.120 |
Why?
| | Pain | 1 | 2001 | 756 | 0.120 |
Why?
| | Weight Gain | 1 | 2019 | 519 | 0.120 |
Why?
| | Biomarkers, Tumor | 2 | 2020 | 1276 | 0.120 |
Why?
| | Amino Acids | 1 | 2019 | 497 | 0.120 |
Why?
| | Adolescent | 12 | 2024 | 21513 | 0.110 |
Why?
| | Circadian Rhythm | 1 | 2019 | 468 | 0.110 |
Why?
| | Biomarkers | 4 | 2023 | 4149 | 0.110 |
Why?
| | RNA, Messenger | 4 | 2014 | 2833 | 0.110 |
Why?
| | Cell Hypoxia | 1 | 2015 | 226 | 0.110 |
Why?
| | Algorithms | 3 | 2015 | 1704 | 0.110 |
Why?
| | Oxygen | 2 | 2015 | 931 | 0.110 |
Why?
| | Venous Thromboembolism | 1 | 2018 | 316 | 0.110 |
Why?
| | Coronary Artery Disease | 2 | 2011 | 698 | 0.110 |
Why?
| | Mitochondria | 2 | 2018 | 948 | 0.110 |
Why?
| | Receptors, AMPA | 1 | 2015 | 141 | 0.110 |
Why?
| | Somatostatin | 1 | 2014 | 61 | 0.110 |
Why?
| | Reactive Oxygen Species | 1 | 2017 | 622 | 0.110 |
Why?
| | Carcinoma, Non-Small-Cell Lung | 1 | 2022 | 1081 | 0.100 |
Why?
| | Fructose | 1 | 2014 | 112 | 0.100 |
Why?
| | Regression Analysis | 1 | 2016 | 1024 | 0.100 |
Why?
| | Neurodegenerative Diseases | 1 | 2015 | 135 | 0.100 |
Why?
| | Clone Cells | 4 | 2000 | 265 | 0.100 |
Why?
| | Fetal Development | 1 | 2016 | 296 | 0.100 |
Why?
| | Cytoplasmic Granules | 1 | 1994 | 93 | 0.100 |
Why?
| | Leg | 3 | 1999 | 236 | 0.100 |
Why?
| | Medroxyprogesterone Acetate | 1 | 2012 | 36 | 0.100 |
Why?
| | Macaca | 3 | 2018 | 56 | 0.100 |
Why?
| | Taxoids | 1 | 2012 | 102 | 0.090 |
Why?
| | Progestins | 1 | 2012 | 79 | 0.090 |
Why?
| | Antigens, Neoplasm | 2 | 1994 | 319 | 0.090 |
Why?
| | Coronary Vessels | 2 | 2010 | 248 | 0.090 |
Why?
| | Myocardial Reperfusion Injury | 1 | 2013 | 135 | 0.090 |
Why?
| | Prenatal Exposure Delayed Effects | 1 | 2018 | 605 | 0.090 |
Why?
| | Cholesterol | 2 | 2013 | 410 | 0.090 |
Why?
| | Gene Expression Regulation | 2 | 2019 | 2607 | 0.090 |
Why?
| | Hemodynamics | 3 | 2008 | 1113 | 0.090 |
Why?
| | Myocardial Contraction | 1 | 2013 | 341 | 0.090 |
Why?
| | Hypoxia | 1 | 2018 | 1112 | 0.090 |
Why?
| | Recovery of Function | 1 | 2015 | 653 | 0.090 |
Why?
| | Reference Values | 2 | 2010 | 816 | 0.090 |
Why?
| | Fenofibrate | 1 | 2011 | 28 | 0.090 |
Why?
| | Child | 9 | 2024 | 21935 | 0.090 |
Why?
| | Sitagliptin Phosphate | 1 | 2010 | 33 | 0.080 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 3 | 2009 | 976 | 0.080 |
Why?
| | Predictive Value of Tests | 2 | 2015 | 2031 | 0.080 |
Why?
| | Estradiol | 2 | 2019 | 521 | 0.080 |
Why?
| | Hypolipidemic Agents | 1 | 2011 | 91 | 0.080 |
Why?
| | Cell Line | 5 | 2022 | 2847 | 0.080 |
Why?
| | Nicotine | 1 | 2012 | 334 | 0.080 |
Why?
| | Retinoid X Receptor gamma | 1 | 2009 | 4 | 0.080 |
Why?
| | C-Peptide | 1 | 2010 | 163 | 0.080 |
Why?
| | Metabolic Clearance Rate | 2 | 2006 | 115 | 0.080 |
Why?
| | PPAR alpha | 1 | 2009 | 58 | 0.080 |
Why?
| | TOR Serine-Threonine Kinases | 1 | 2012 | 412 | 0.080 |
Why?
| | Expiratory Reserve Volume | 1 | 2008 | 1 | 0.080 |
Why?
| | Bicycling | 1 | 2010 | 114 | 0.080 |
Why?
| | Lipoproteins | 1 | 2010 | 168 | 0.080 |
Why?
| | Calcinosis | 1 | 2011 | 235 | 0.080 |
Why?
| | Gene Expression | 3 | 2023 | 1502 | 0.070 |
Why?
| | Mice, Inbred C57BL | 2 | 2023 | 5757 | 0.070 |
Why?
| | Proteins | 3 | 2015 | 1009 | 0.070 |
Why?
| | Coronary Circulation | 1 | 2008 | 143 | 0.070 |
Why?
| | Ethinyl Estradiol | 1 | 1988 | 16 | 0.070 |
Why?
| | Signal Transduction | 4 | 2018 | 5079 | 0.070 |
Why?
| | Calcium | 2 | 2010 | 1199 | 0.070 |
Why?
| | Arteries | 2 | 2000 | 269 | 0.070 |
Why?
| | Receptor, Insulin | 1 | 2007 | 105 | 0.070 |
Why?
| | Drug Resistance, Neoplasm | 1 | 2012 | 801 | 0.070 |
Why?
| | Regional Blood Flow | 2 | 1999 | 474 | 0.070 |
Why?
| | Pancreatic Neoplasms | 2 | 1999 | 938 | 0.070 |
Why?
| | Hyperphagia | 1 | 2006 | 34 | 0.060 |
Why?
| | Cardiovascular Diseases | 3 | 2018 | 2111 | 0.060 |
Why?
| | Overweight | 1 | 2011 | 558 | 0.060 |
Why?
| | Adaptation, Physiological | 1 | 2010 | 553 | 0.060 |
Why?
| | Heart | 1 | 2009 | 655 | 0.060 |
Why?
| | Substance Withdrawal Syndrome | 1 | 1988 | 179 | 0.060 |
Why?
| | Infant | 3 | 2024 | 9465 | 0.060 |
Why?
| | Sex Factors | 4 | 2018 | 2071 | 0.060 |
Why?
| | Sex Hormone-Binding Globulin | 2 | 2019 | 59 | 0.050 |
Why?
| | Glucose-6-Phosphatase | 2 | 2001 | 33 | 0.050 |
Why?
| | ARNTL Transcription Factors | 1 | 2023 | 17 | 0.050 |
Why?
| | Ubiquinone | 1 | 2023 | 29 | 0.050 |
Why?
| | Uncoupling Protein 1 | 1 | 2023 | 16 | 0.050 |
Why?
| | Pyruvic Acid | 1 | 2004 | 53 | 0.050 |
Why?
| | Adipogenesis | 1 | 2024 | 55 | 0.050 |
Why?
| | Metabolome | 2 | 2019 | 350 | 0.050 |
Why?
| | Cardiorespiratory Fitness | 1 | 2024 | 55 | 0.050 |
Why?
| | Electron Transport | 1 | 2023 | 115 | 0.050 |
Why?
| | Thermogenesis | 1 | 2023 | 44 | 0.050 |
Why?
| | Adipose Tissue, Brown | 1 | 2023 | 53 | 0.050 |
Why?
| | Carbohydrate Metabolism | 2 | 2004 | 59 | 0.050 |
Why?
| | Aged | 6 | 2018 | 23961 | 0.050 |
Why?
| | Physical Exertion | 1 | 2004 | 215 | 0.050 |
Why?
| | AMP-Activated Protein Kinases | 1 | 2024 | 197 | 0.050 |
Why?
| | Insulin, Regular, Human | 1 | 2022 | 43 | 0.050 |
Why?
| | Severity of Illness Index | 1 | 2010 | 2828 | 0.050 |
Why?
| | Diet, High-Fat | 1 | 2023 | 247 | 0.050 |
Why?
| | Prognosis | 2 | 2023 | 4030 | 0.050 |
Why?
| | Primates | 1 | 2023 | 126 | 0.050 |
Why?
| | Time Factors | 2 | 2010 | 6828 | 0.050 |
Why?
| | Neoplasms | 1 | 2017 | 2671 | 0.050 |
Why?
| | Osteocalcin | 1 | 2021 | 37 | 0.050 |
Why?
| | Protein Binding | 2 | 2018 | 2224 | 0.050 |
Why?
| | Swine, Miniature | 2 | 2013 | 82 | 0.040 |
Why?
| | Acute Disease | 1 | 2024 | 1007 | 0.040 |
Why?
| | Mice, Transgenic | 1 | 2006 | 2167 | 0.040 |
Why?
| | Diabetes Mellitus, Experimental | 2 | 2015 | 195 | 0.040 |
Why?
| | Muscle Strength | 1 | 2024 | 317 | 0.040 |
Why?
| | Ranolazine | 1 | 2020 | 25 | 0.040 |
Why?
| | Antineoplastic Agents | 1 | 2012 | 2129 | 0.040 |
Why?
| | Oxidative Stress | 2 | 2018 | 1317 | 0.040 |
Why?
| | Torque | 1 | 2001 | 84 | 0.040 |
Why?
| | Collagen Type I | 1 | 2021 | 136 | 0.040 |
Why?
| | Adenocarcinoma | 1 | 1988 | 940 | 0.040 |
Why?
| | Electrodes | 1 | 2001 | 114 | 0.040 |
Why?
| | Testosterone | 2 | 2019 | 409 | 0.040 |
Why?
| | Chromatography, Ion Exchange | 1 | 2000 | 55 | 0.040 |
Why?
| | Detergents | 1 | 2000 | 44 | 0.040 |
Why?
| | Oncogene Proteins, Fusion | 1 | 2022 | 215 | 0.040 |
Why?
| | Chromatography, Gel | 1 | 2000 | 127 | 0.040 |
Why?
| | Cytotoxicity, Immunologic | 1 | 2020 | 224 | 0.040 |
Why?
| | Serine | 1 | 2021 | 141 | 0.040 |
Why?
| | L-Lactate Dehydrogenase | 1 | 2000 | 122 | 0.040 |
Why?
| | Electrophoresis, Polyacrylamide Gel | 1 | 2000 | 345 | 0.040 |
Why?
| | Solubility | 1 | 2000 | 245 | 0.040 |
Why?
| | Cell Membrane | 2 | 2000 | 738 | 0.040 |
Why?
| | Tumor Burden | 1 | 2020 | 309 | 0.040 |
Why?
| | Glycogen | 1 | 1999 | 55 | 0.040 |
Why?
| | Mice, SCID | 1 | 2000 | 367 | 0.040 |
Why?
| | Epitopes, T-Lymphocyte | 1 | 2000 | 181 | 0.040 |
Why?
| | Proto-Oncogene Proteins c-akt | 2 | 2013 | 437 | 0.040 |
Why?
| | Isometric Contraction | 1 | 2001 | 188 | 0.040 |
Why?
| | Eating | 1 | 2021 | 380 | 0.040 |
Why?
| | Glucose Transporter Type 4 | 1 | 2018 | 40 | 0.040 |
Why?
| | Swine | 2 | 2013 | 775 | 0.040 |
Why?
| | Osmolar Concentration | 1 | 1999 | 171 | 0.040 |
Why?
| | Glucagon | 1 | 1999 | 109 | 0.040 |
Why?
| | Thromboplastin | 1 | 2018 | 74 | 0.040 |
Why?
| | Rats, Sprague-Dawley | 1 | 2024 | 2486 | 0.040 |
Why?
| | Muscle Proteins | 1 | 2000 | 231 | 0.040 |
Why?
| | Pilot Projects | 1 | 2023 | 1710 | 0.040 |
Why?
| | Postprandial Period | 1 | 1999 | 107 | 0.040 |
Why?
| | Disease Models, Animal | 3 | 2015 | 4295 | 0.040 |
Why?
| | Perception | 1 | 2001 | 359 | 0.040 |
Why?
| | Molecular Targeted Therapy | 1 | 2020 | 411 | 0.030 |
Why?
| | Research Design | 1 | 2024 | 1139 | 0.030 |
Why?
| | Dendritic Cells | 1 | 2020 | 483 | 0.030 |
Why?
| | Immunity, Innate | 1 | 2023 | 828 | 0.030 |
Why?
| | Random Allocation | 1 | 2018 | 353 | 0.030 |
Why?
| | Disease-Free Survival | 1 | 2018 | 686 | 0.030 |
Why?
| | Carbon Dioxide | 1 | 1999 | 267 | 0.030 |
Why?
| | Cell Proliferation | 2 | 2015 | 2475 | 0.030 |
Why?
| | Protein Kinase Inhibitors | 1 | 2022 | 916 | 0.030 |
Why?
| | Endoplasmic Reticulum Stress | 1 | 2017 | 110 | 0.030 |
Why?
| | Nutritional Status | 1 | 1999 | 350 | 0.030 |
Why?
| | Cell Line, Tumor | 2 | 2015 | 3412 | 0.030 |
Why?
| | Carrier Proteins | 1 | 2000 | 771 | 0.030 |
Why?
| | Waist Circumference | 1 | 2015 | 143 | 0.030 |
Why?
| | Deuterium | 1 | 2015 | 99 | 0.030 |
Why?
| | HeLa Cells | 1 | 2017 | 636 | 0.030 |
Why?
| | Androgens | 1 | 2016 | 187 | 0.030 |
Why?
| | Prospective Studies | 2 | 2018 | 7604 | 0.030 |
Why?
| | Lymphocyte Activation | 3 | 1994 | 1142 | 0.030 |
Why?
| | Epitopes | 1 | 1997 | 479 | 0.030 |
Why?
| | Double-Blind Method | 1 | 2019 | 1993 | 0.030 |
Why?
| | Protein Subunits | 1 | 2015 | 239 | 0.030 |
Why?
| | CD8-Positive T-Lymphocytes | 1 | 2020 | 900 | 0.030 |
Why?
| | Centrifugation, Density Gradient | 1 | 1994 | 41 | 0.030 |
Why?
| | Autophagy | 1 | 2017 | 284 | 0.030 |
Why?
| | Culture Techniques | 1 | 1994 | 81 | 0.030 |
Why?
| | Cell Fractionation | 1 | 1994 | 56 | 0.030 |
Why?
| | Animal Feed | 1 | 2014 | 53 | 0.030 |
Why?
| | Survival Rate | 1 | 2018 | 1972 | 0.030 |
Why?
| | T-Lymphocytes, Regulatory | 1 | 1997 | 385 | 0.030 |
Why?
| | Neoplasm Invasiveness | 1 | 2015 | 510 | 0.030 |
Why?
| | Membrane Proteins | 1 | 2000 | 1164 | 0.030 |
Why?
| | Memory | 1 | 2015 | 248 | 0.030 |
Why?
| | Mice, Inbred Strains | 1 | 1994 | 409 | 0.030 |
Why?
| | Acyl Coenzyme A | 1 | 2013 | 31 | 0.030 |
Why?
| | Amyloid beta-Peptides | 1 | 2015 | 220 | 0.020 |
Why?
| | Heart Function Tests | 1 | 2013 | 59 | 0.020 |
Why?
| | Infant, Newborn | 1 | 2024 | 6079 | 0.020 |
Why?
| | Macrophage Activation | 1 | 2014 | 201 | 0.020 |
Why?
| | Risk Factors | 3 | 2012 | 10388 | 0.020 |
Why?
| | Gonanes | 1 | 2012 | 27 | 0.020 |
Why?
| | Prevalence | 1 | 2019 | 2734 | 0.020 |
Why?
| | Cardiolipins | 1 | 2013 | 85 | 0.020 |
Why?
| | Anaerobic Threshold | 2 | 2004 | 28 | 0.020 |
Why?
| | Models, Theoretical | 1 | 2015 | 578 | 0.020 |
Why?
| | Tumor Cells, Cultured | 1 | 1994 | 955 | 0.020 |
Why?
| | Cerebral Cortex | 1 | 2015 | 433 | 0.020 |
Why?
| | Antigen-Presenting Cells | 1 | 1992 | 156 | 0.020 |
Why?
| | Behavior, Animal | 1 | 2015 | 501 | 0.020 |
Why?
| | Fetus | 1 | 2016 | 806 | 0.020 |
Why?
| | Amino Acid Sequence | 3 | 2001 | 2139 | 0.020 |
Why?
| | Abdominal Fat | 1 | 2012 | 41 | 0.020 |
Why?
| | Incidence | 1 | 2018 | 2804 | 0.020 |
Why?
| | Molecular Weight | 1 | 2012 | 335 | 0.020 |
Why?
| | Models, Statistical | 1 | 2015 | 669 | 0.020 |
Why?
| | Cognition Disorders | 1 | 2015 | 496 | 0.020 |
Why?
| | Learning | 1 | 2015 | 409 | 0.020 |
Why?
| | Molecular Sequence Data | 3 | 2001 | 2900 | 0.020 |
Why?
| | MAP Kinase Signaling System | 1 | 2013 | 320 | 0.020 |
Why?
| | Tomography, X-Ray Computed | 2 | 2010 | 2691 | 0.020 |
Why?
| | Receptors, Progesterone | 1 | 2012 | 350 | 0.020 |
Why?
| | Cholesterol, HDL | 1 | 2011 | 203 | 0.020 |
Why?
| | Genotype | 1 | 2015 | 1916 | 0.020 |
Why?
| | Hippocampus | 1 | 2015 | 895 | 0.020 |
Why?
| | Abdomen | 1 | 2010 | 125 | 0.020 |
Why?
| | Sex Distribution | 1 | 2010 | 375 | 0.020 |
Why?
| | Child, Preschool | 1 | 2024 | 11074 | 0.020 |
Why?
| | Conserved Sequence | 2 | 2001 | 239 | 0.020 |
Why?
| | Sequence Alignment | 2 | 2001 | 343 | 0.020 |
Why?
| | Follow-Up Studies | 1 | 2018 | 5131 | 0.020 |
Why?
| | Cloning, Molecular | 2 | 2001 | 534 | 0.020 |
Why?
| | Chi-Square Distribution | 1 | 2010 | 530 | 0.020 |
Why?
| | Spleen | 1 | 2010 | 514 | 0.020 |
Why?
| | Mice, Knockout | 1 | 2015 | 3015 | 0.020 |
Why?
| | Leydig Cells | 1 | 1988 | 15 | 0.020 |
Why?
| | Gonadotropins, Pituitary | 1 | 1988 | 22 | 0.020 |
Why?
| | Chromatography, Liquid | 1 | 2010 | 433 | 0.020 |
Why?
| | Environmental Monitoring | 1 | 2010 | 370 | 0.020 |
Why?
| | Apoptosis | 1 | 2017 | 2553 | 0.020 |
Why?
| | Phosphatidylinositol 3-Kinases | 1 | 2009 | 366 | 0.020 |
Why?
| | B-Lymphocytes | 1 | 1992 | 847 | 0.020 |
Why?
| | Magnetic Resonance Imaging | 1 | 2018 | 3566 | 0.020 |
Why?
| | Base Sequence | 2 | 2001 | 2181 | 0.020 |
Why?
| | Macrophages | 1 | 2014 | 1547 | 0.020 |
Why?
| | Patient Selection | 1 | 2010 | 696 | 0.020 |
Why?
| | Cytokines | 1 | 2014 | 2085 | 0.020 |
Why?
| | Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2010 | 445 | 0.020 |
Why?
| | Age Factors | 1 | 2012 | 3295 | 0.010 |
Why?
| | Femoral Vein | 1 | 2004 | 34 | 0.010 |
Why?
| | Gas Chromatography-Mass Spectrometry | 1 | 2004 | 132 | 0.010 |
Why?
| | Hormones | 1 | 2004 | 143 | 0.010 |
Why?
| | Alanine | 1 | 2004 | 152 | 0.010 |
Why?
| | Inflammation | 1 | 2014 | 2837 | 0.010 |
Why?
| | Femoral Artery | 1 | 2004 | 179 | 0.010 |
Why?
| | Blood Pressure | 1 | 2009 | 1786 | 0.010 |
Why?
| | Glycolysis | 1 | 2004 | 321 | 0.010 |
Why?
| | Diabetes Mellitus | 1 | 2010 | 1040 | 0.010 |
Why?
| | Immunoenzyme Techniques | 1 | 2001 | 219 | 0.010 |
Why?
| | Monocarboxylic Acid Transporters | 1 | 2000 | 22 | 0.010 |
Why?
| | Catalytic Domain | 1 | 2001 | 207 | 0.010 |
Why?
| | Prostaglandin-Endoperoxide Synthases | 1 | 2000 | 77 | 0.010 |
Why?
| | Breast Neoplasms | 1 | 2012 | 2253 | 0.010 |
Why?
| | Isoenzymes | 1 | 2000 | 304 | 0.010 |
Why?
| | Mice, Obese | 1 | 1999 | 66 | 0.010 |
Why?
| | Myosin Heavy Chains | 1 | 2000 | 192 | 0.010 |
Why?
| | Fishes | 1 | 1999 | 105 | 0.010 |
Why?
| | Open Reading Frames | 1 | 1999 | 123 | 0.010 |
Why?
| | Sequence Homology, Amino Acid | 1 | 1999 | 385 | 0.010 |
Why?
| | Protein Structure, Secondary | 1 | 1999 | 374 | 0.010 |
Why?
| | Exons | 1 | 1999 | 355 | 0.010 |
Why?
| | Dogs | 1 | 1999 | 413 | 0.010 |
Why?
| | Alternative Splicing | 1 | 1999 | 229 | 0.010 |
Why?
| | Promoter Regions, Genetic | 1 | 2001 | 1250 | 0.010 |
Why?
| | Mice, Inbred BALB C | 1 | 1999 | 1272 | 0.010 |
Why?
| | Models, Molecular | 1 | 1999 | 1570 | 0.010 |
Why?
| | Genetic Variation | 1 | 1999 | 991 | 0.010 |
Why?
| | Trinitrobenzenes | 1 | 1992 | 14 | 0.010 |
Why?
| | Adenoma, Islet Cell | 1 | 1992 | 8 | 0.010 |
Why?
| | Hybrid Cells | 1 | 1992 | 49 | 0.010 |
Why?
| | Haptens | 1 | 1992 | 22 | 0.010 |
Why?
| | Ovalbumin | 1 | 1992 | 183 | 0.010 |
Why?
| | Receptors, Antigen, B-Cell | 1 | 1992 | 130 | 0.010 |
Why?
| | Interleukin-2 | 1 | 1992 | 455 | 0.010 |
Why?
| | Mice, Mutant Strains | 1 | 1989 | 298 | 0.000 |
Why?
| | Islets of Langerhans Transplantation | 1 | 1989 | 64 | 0.000 |
Why?
| | Pituitary Gland | 1 | 1989 | 148 | 0.000 |
Why?
|
|
Bergman's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|